FMR1 and fragile X syndrome: MPEP is effective in treating autism-related symptoms in the Fmr1 mouse model of Fragile X syndrome [181–184], and fluoxetine is under evaluation to treat repetitive behavior and anxiety in autistic patients and is currently used to treat depression [180].